{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:56:46Z","timestamp":1785380206628,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most frequent cause of dementia and still lacks effective therapy. Clinical signs of AD include low levels of endogenous melanocortins (MCs) and previous studies have shown that treatment with MC analogs induces neuroprotection in the early stages of AD. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated the neuroprotective role of MCs in two transgenic mouse models of severe AD using 5 and 7 month-old (mo) 5XFAD mice and 9 and 12 mo 3xTg mice. These mice were subjected to a chronic stimulation of MC receptors (MCRs) with MC analogue Nle4-D-Phe7-\u03b1-melanocyte stimulating hormone (NDP-\u03b1-MSH, 340 \u03bcg\/kg, i.p.). Mouse behavior and ex-vivo histological and biochemical analyses were performed after 50 days of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our analysis demonstrated an improvement in cognitive abilities of AD mice at late stage of AD progression. We also showed that these protective effects are associated with decreased levels of hyperphosphorylated Tau but not with A\u03b2 burden, that was unaffected in the hippocampus and in the cortex of AD mice. In addition, an age-dependent NDP effect on glial reactivity was observed only in 3xTg mice whereas a global downregulation of p38 mitogen-activated protein kinase was selectively observed in 7 mo 5XFAD and 14 mo 3xTg mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that MCR stimulation by NDP-\u03b1-MSH could represent a promising therapeutic strategy in managing cognitive decline also at late stage of AD, whereas the effects on neuroinflammation may be restricted to specific stages of AD progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1082036","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T21:25:22Z","timestamp":1673385922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Melanocortin receptor agonist NDP-\u03b1-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Eleonora","family":"Daini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Vandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bodria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ottani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer's disease: Epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041160","article-title":"An overview on the clinical development of tau-based therapeutics","volume":"19","author":"Medina","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2022.06.012","article-title":"High-clearance anti-amyloid immunotherapies in alzheimer's disease. part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects","author":"Villain","year":"2022","journal-title":"Rev Neurol (Paris)."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1215431","article-title":"Pharmacotherapeutic strategies in the treatment of severe alzheimer's disease","volume":"17","author":"Deardorff","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for alzheimer's disease in clinical trials","volume":"68","author":"Godyn","year":"2016","journal-title":"Pharmacol Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1586\/14737175.2015.995637","article-title":"Advances in the therapy of alzheimer's disease: Targeting amyloid beta and tau and perspectives for the future","volume":"15","author":"Hampel","year":"2015","journal-title":"Expert Rev Neurother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"111cm133","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2021.02.015","article-title":"Altered hippocampal astroglial metabolism is associated with aging and preserved spatial learning and memory","volume":"102","author":"Ebersole","year":"2021","journal-title":"Neurobiol Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.08.030","article-title":"Melanocortins protect against progression of alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways","volume":"35","author":"Giuliani","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"135869","DOI":"10.1016\/j.neulet.2021.135869","article-title":"A regional and cellular analysis of the early intracellular and extracellular accumulation of abeta in the brain of 5XFAD mice","volume":"754","author":"Daini","year":"2021","journal-title":"Neurosci Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00233","article-title":"Microglia in Alzheimer disease: Well-known targets and new opportunities","volume":"11","author":"Hemonnot","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"B13","article-title":"Pathogenesis of alzheimer's disease","volume":"2","author":"Swerdlow","year":"2007","journal-title":"Clin Interv. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.4268","article-title":"Microglial\/Macrophage polarization dynamics following traumatic brain injury","volume":"33","author":"Kumar","year":"2016","journal-title":"J Neurotrauma."},{"key":"B16","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-18-0596","article-title":"The melanocortin pathway and control of appetite-progress and therapeutic implications","volume":"241","author":"Baldini","year":"2019","journal-title":"J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0692","article-title":"Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia","volume":"147","author":"Giuliani","year":"2006","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.bjp.0707115","article-title":"Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage","volume":"150","author":"Giuliani","year":"2007","journal-title":"Br J Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318236efde","article-title":"Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*","volume":"40","author":"Bitto","year":"2012","journal-title":"Crit Care Med"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057313","article-title":"Effect of NDP-alpha-MSH on PPAR-gamma and -beta expression and anti-inflammatory cytokine release in rat astrocytes and microglia","volume":"8","author":"Carniglia","year":"2013","journal-title":"PLos One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.05.004","article-title":"NDP-alpha-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors","volume":"67","author":"Giuliani","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pneurobio.2016.11.004","article-title":"Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives","volume":"148","author":"Giuliani","year":"2017","journal-title":"Prog Neurobiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of alzheimer's disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of alzheimer's disease with plaques and tangles: Intracellular abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(95)00043-J","article-title":"Permeability of the blood-brain barrier to melanocortins","volume":"16","author":"Banks","year":"1995","journal-title":"Peptides"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.10.022","article-title":"Protective effects of the melanocortin analog NDP-alpha-MSH in rats undergoing cardiac arrest","volume":"745","author":"Ottani","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121330","article-title":"Identification of a thyroid hormone derivative as a pleiotropic agent for the treatment of alzheimer's disease","volume":"14","author":"Runfola","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B28","article-title":"Paxinos and Franklin's The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2019","journal-title":"Elsevier"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.06.063","article-title":"Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate alzheimers disease","volume":"740","author":"Giuliani","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.019","article-title":"LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response","volume":"74","author":"Rigillo","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.03.009","article-title":"Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268","volume":"23","author":"Giuliani","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.03.005","article-title":"Modulation of the JAK\/ERK\/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia\/reperfusion","volume":"72","author":"Ottani","year":"2013","journal-title":"Pharmacol Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041224","article-title":"Differential signaling profiles of MC4R mutations with three different ligands","volume":"21","author":"Paisdzior","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.043","article-title":"Stimulation of the hippocampal POMC\/MC4R circuit alleviates synaptic plasticity impairment in an alzheimer's disease model","volume":"17","author":"Shen","year":"2016","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.104","article-title":"Melanocortin MC(4) receptor expression sites and local function","volume":"660","author":"Siljee-Wong","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.12.020","article-title":"Structure, function and regulation of the melanocortin receptors","volume":"660","author":"Yang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3300-12.2012","article-title":"SRPK2 phosphorylates tau and mediates the cognitive defects in alzheimer's disease","volume":"32","author":"Hong","year":"2012","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-019-1591-4","article-title":"NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB\/Nr4a1\/NF-kappaB pathway after intracerebral hemorrhage in mice","volume":"16","author":"Wu","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1038\/s41598-021-83932-4","article-title":"Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an alzheimer's disease transgenic mouse model","volume":"11","author":"Lau","year":"2021","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.63.6.740","article-title":"Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia","volume":"63","author":"Delgado","year":"1998","journal-title":"J Leukoc Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12974-018-1140-6","article-title":"Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK\/JNK\/p38 MAPK pathway after intracerebral hemorrhage in mice","volume":"15","author":"Chen","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-06-02181.1997","article-title":"Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation","volume":"17","author":"Rajora","year":"1997","journal-title":"J Neurosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2018.00008","article-title":"Olig2-lineage astrocytes: A distinct subtype of astrocytes that differs from GFAP astrocytes","volume":"12","author":"Tatsumi","year":"2018","journal-title":"Front Neuroanat."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8080143","article-title":"New insights into GFAP negative astrocytes in calbindin D28k immunoreactive astrocytes","volume":"8","author":"Xu","year":"2018","journal-title":"Brain Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1082036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T21:25:29Z","timestamp":1673385929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1082036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2022.1082036"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1082036","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1082036"}}